Carman Alenson

Insider Reports History

Location
88 Sidney Street, Cambridge, MA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carman Alenson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Exhibit 24 - Power of Attorney Stock Option (right to buy) 90.5K Aug 1, 2025 Direct
AGIOS PHARMACEUTICALS, INC. Principal Accounting Officer Stock option (right to buy) 3.56K Jun 21, 2021 Direct
AGIOS PHARMACEUTICALS, INC. Principal Accounting Officer Common stock 0 $21.64 Jun 21, 2021 Direct

Insider Reports Filed by Carman Alenson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Aug 1, 2025 8 $0 4 Aug 5, 2025 Exhibit 24 - Power of Attorney
PRME Prime Medicine, Inc. Feb 27, 2025 1 $0 4 Mar 3, 2025 SVP, Finance and Chief Accounting Officer
PRME Prime Medicine, Inc. Feb 21, 2024 1 $0 4 Feb 23, 2024 SVP, Finance and Chief Accounting Officer
PRME Prime Medicine, Inc. Apr 18, 2023 1 $0 4 Apr 20, 2023 Officer
PRME Prime Medicine, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Interim Chief Financial Officer and Chief Accounting Officer
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Interim Chief Financial Officer and Chief Accounting Officer. Exhibit 24 - Power of Attorney
AGIO AGIOS PHARMACEUTICALS, INC. Jun 21, 2021 3 -$17.9K 4 Jun 23, 2021 Principal Accounting Officer